Evidence map›Paper›PMID 37293542›Full record

ArticleFrontiers in molecular neuroscience2023

Combined treatment with Sigma1R and A2AR agonists fails to inhibit cocaine self-administration despite causing strong antagonistic accumbal A2AR-D2R complex interactions: the potential role of astrocytes.

Dasiel O Borroto-Escuela, Alexander Lopez-Salas, Karolina Wydra, Marco Bartolini, Zilong Zhou, Malgorzata Frankowska, Agata Suder, Javier Benitez-Porres, Wilber Romero-Fernandez, Malgorzata Filip and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 6 countries.

Dasiel O Borroto-EscuelaDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Alexander Lopez-SalasDepartment of Human Physiology, Physical Education and Sport, Universidad de Málaga, Málaga, Spain.
Karolina WydraMaj Institute of Pharmacology Polish Academy of Sciences, Department of Drug Addiction Pharmacology, Kraków, Poland.
Marco BartoliniDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Zilong ZhouDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Malgorzata FrankowskaMaj Institute of Pharmacology Polish Academy of Sciences, Department of Drug Addiction Pharmacology, Kraków, Poland.
Agata SuderMaj Institute of Pharmacology Polish Academy of Sciences, Department of Drug Addiction Pharmacology, Kraków, Poland.
Javier Benitez-PorresDepartment of Human Physiology, Physical Education and Sport, Universidad de Málaga, Málaga, Spain.
Wilber Romero-FernandezDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Malgorzata FilipMaj Institute of Pharmacology Polish Academy of Sciences, Department of Drug Addiction Pharmacology, Kraków, Poland.
Kjell FuxeDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEMaj Institute of Pharmacology · PLPolish Academy of Sciences · PLUniversidad de Málaga · ESNortheast Normal University · CNUniversity of Milan · ITUniversity of Urbino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have indicated that acute treatment with the monoamine stabilizer OSU-6162 (5 mg/kg), which has a high affinity for Sigma1R, significantly increased the density of accumbal shell D2R-Sigma1R and A2AR-D2R heteroreceptor complexes following cocaine self-administration.

Indexed as

A2AR-D2R heteroreceptor complexesallosteric receptor-receptor interactionscocaine use disorderG protein coupled receptor (GPCR)monoamine stabilizeroligomerizationSigma 1 receptor

Identifiers

PMID37293542
PMCPMC10246738
OpenAlexW4377942924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.